Correlation Between Beleave and Aequus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Beleave and Aequus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beleave and Aequus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beleave and Aequus Pharmaceuticals, you can compare the effects of market volatilities on Beleave and Aequus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beleave with a short position of Aequus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beleave and Aequus Pharmaceuticals.
Diversification Opportunities for Beleave and Aequus Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Beleave and Aequus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Beleave and Aequus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aequus Pharmaceuticals and Beleave is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beleave are associated (or correlated) with Aequus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aequus Pharmaceuticals has no effect on the direction of Beleave i.e., Beleave and Aequus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Beleave and Aequus Pharmaceuticals
If you would invest (100.00) in Beleave on August 25, 2024 and sell it today you would earn a total of 100.00 from holding Beleave or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Beleave vs. Aequus Pharmaceuticals
Performance |
| Timeline |
| Beleave |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aequus Pharmaceuticals |
Beleave and Aequus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Beleave and Aequus Pharmaceuticals
The main advantage of trading using opposite Beleave and Aequus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beleave position performs unexpectedly, Aequus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will offset losses from the drop in Aequus Pharmaceuticals' long position.| Beleave vs. Pharmacielo | Beleave vs. Amexdrug | Beleave vs. The BC Bud | Beleave vs. Speakeasy Cannabis Club |
| Aequus Pharmaceuticals vs. Rezolute | Aequus Pharmaceuticals vs. Tempest Therapeutics | Aequus Pharmaceuticals vs. Forte Biosciences | Aequus Pharmaceuticals vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |